Syndax Pharmaceuticals, Inc. (SNDX)
USD 11.18
(-10.27%)
USD 11.18
(-10.27%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -293.75 Million USD | -301.34% |
| 2022 | -73.19 Million USD | 63.58% |
| 2021 | -200.99 Million USD | -112.23% |
| 2020 | -94.7 Million USD | -299.41% |
| 2019 | -23.71 Million USD | 29.78% |
| 2018 | -33.76 Million USD | 3.98% |
| 2017 | -35.16 Million USD | -47.49% |
| 2016 | -23.84 Million USD | -2.87% |
| 2015 | -23.17 Million USD | -698.17% |
| 2014 | 3.87 Million USD | 138.35% |
| 2013 | -10.1 Million USD | -148.56% |
| 2012 | 20.8 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -113.22 Million USD | 61.46% |
| 2024 Q2 | -104.26 Million USD | 7.91% |
| 2024 Q3 | -133.01 Million USD | -26.76% |
| 2023 Q4 | -293.75 Million USD | -216.96% |
| 2023 FY | -293.75 Million USD | -301.34% |
| 2023 Q3 | -92.68 Million USD | 2.62% |
| 2023 Q1 | -56.45 Million USD | 22.87% |
| 2023 Q2 | -95.17 Million USD | -68.58% |
| 2022 Q1 | -167.75 Million USD | 16.54% |
| 2022 FY | -73.19 Million USD | 63.58% |
| 2022 Q4 | -73.19 Million USD | -4.39% |
| 2022 Q3 | -70.12 Million USD | 29.28% |
| 2022 Q2 | -99.15 Million USD | 40.89% |
| 2021 Q4 | -200.99 Million USD | -303.71% |
| 2021 Q3 | -49.78 Million USD | -5.33% |
| 2021 Q1 | -43.61 Million USD | 53.95% |
| 2021 Q2 | -47.26 Million USD | -8.38% |
| 2021 FY | -200.99 Million USD | -112.23% |
| 2020 Q2 | -33.04 Million USD | -37.41% |
| 2020 Q1 | -24.05 Million USD | -1.43% |
| 2020 Q4 | -94.7 Million USD | -164.51% |
| 2020 FY | -94.7 Million USD | -299.41% |
| 2020 Q3 | -35.8 Million USD | -8.34% |
| 2019 Q2 | -25.41 Million USD | 55.23% |
| 2019 Q4 | -23.71 Million USD | 19.83% |
| 2019 FY | -23.71 Million USD | 29.78% |
| 2019 Q1 | -56.76 Million USD | -68.09% |
| 2019 Q3 | -29.57 Million USD | -16.4% |
| 2018 Q3 | -26.7 Million USD | 17.08% |
| 2018 FY | -33.76 Million USD | 3.98% |
| 2018 Q4 | -33.76 Million USD | -26.45% |
| 2018 Q2 | -32.2 Million USD | -15.09% |
| 2018 Q1 | -27.98 Million USD | 20.44% |
| 2017 Q1 | -22.35 Million USD | 6.24% |
| 2017 FY | -35.16 Million USD | -47.49% |
| 2017 Q4 | -35.16 Million USD | -69.63% |
| 2017 Q3 | -20.73 Million USD | 9.81% |
| 2017 Q2 | -22.98 Million USD | -2.83% |
| 2016 Q3 | -12.75 Million USD | 11.69% |
| 2016 FY | -23.84 Million USD | -2.87% |
| 2016 Q1 | -23.18 Million USD | -0.03% |
| 2016 Q4 | -23.84 Million USD | -86.97% |
| 2016 Q2 | -14.44 Million USD | 37.72% |
| 2015 Q1 | 12.2 Million USD | 215.05% |
| 2015 FY | -23.17 Million USD | -698.17% |
| 2015 Q4 | -23.17 Million USD | 49.65% |
| 2015 Q3 | -46.03 Million USD | 0.0% |
| 2014 Q2 | -4.68 Million USD | 31.58% |
| 2014 Q3 | -1.77 Million USD | 62.14% |
| 2014 Q4 | 3.87 Million USD | 318.68% |
| 2014 FY | 3.87 Million USD | 138.35% |
| 2014 Q1 | -6.84 Million USD | 32.3% |
| 2013 FY | -10.1 Million USD | -148.56% |
| 2013 Q4 | -10.1 Million USD | -184.78% |
| 2013 Q3 | -3.54 Million USD | 0.0% |
| 2013 Q1 | 628.00 USD | 216.95% |
| 2012 FY | 20.8 Million USD | 0.0% |
| 2012 Q4 | -537.00 USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -425.132% |
| Alkermes plc | -166.73 Million USD | -76.179% |
| Agenus Inc. | 274.13 Million USD | 207.158% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 115.71% |
| Aptorum Group Limited | 1.35 Million USD | 21746.945% |
| Ardelyx, Inc. | 34.51 Million USD | 951.179% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 6963.528% |
| Bicycle Therapeutics plc | -481.46 Million USD | 38.987% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 912.319% |
| ChromaDex Corporation | -24.04 Million USD | -1121.553% |
| Chimerix, Inc. | -25.51 Million USD | -1051.229% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 4315.784% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -1140.694% |
| CRISPR Therapeutics AG | -150.84 Million USD | -94.742% |
| Precision BioSciences, Inc. | -85.41 Million USD | -243.94% |
| Dyadic International, Inc. | -6.37 Million USD | -4505.745% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -1743.714% |
| Fortress Biotech, Inc. | 7.66 Million USD | 3932.472% |
| Lantern Pharma Inc. | -21.7 Million USD | -1253.524% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -165.756% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -3338.522% |
| Incyte Corporation | -3.17 Billion USD | 90.748% |
| IO Biotech, Inc. | -140.69 Million USD | -108.785% |
| Jaguar Health, Inc. | 29.39 Million USD | 1099.486% |
| Novavax, Inc. | -298.29 Million USD | 1.52% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 5604.197% |
| Opthea Limited | 28.15 Million USD | 1143.273% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -1649.711% |
| ContextLogic Inc. | -232 Million USD | -26.62% |
| MiMedx Group, Inc. | -33.9 Million USD | -766.52% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 2981.403% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -12578.273% |
| NextCure, Inc. | -6.47 Million USD | -4435.418% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -481.689% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -4505.095% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 2515.132% |
| Vaxcyte, Inc. | -368.22 Million USD | 20.223% |
| PDS Biotechnology Corporation | -32.7 Million USD | -798.101% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1800.191% |
| Pharming Group N.V. | 109.8 Million USD | 367.53% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -1588.658% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -67.642% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1486.184% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1486.184% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -4037.451% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -4912.952% |
| Acelyrin, Inc. | -216.9 Million USD | -35.433% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -5136.097% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -16939.385% |
| Summit Therapeutics Inc. | 34.67 Million USD | 947.203% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -4218.08% |
| Senti Biosciences, Inc. | 1.74 Million USD | 16982.701% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -59.127% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -279.284% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -4745.909% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 294539.154% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 46876.911% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -150.977% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -74.614% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 364.958% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -3767.285% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -127.519% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 4360.713% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -21.206% |
| Immix Biopharma, Inc. | -17.5 Million USD | -1577.684% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 7.245% |
| MEI Pharma, Inc. | -3.7 Million USD | -7828.718% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 2448.006% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 281.622% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 1156.953% |
| Fortress Biotech, Inc. | 7.66 Million USD | 3932.472% |
| Precigen, Inc. | -481 Thousand USD | -60972.557% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 2186.208% |
| AlloVir, Inc. | -62.69 Million USD | -368.575% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -428.211% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 576.371% |
| ImmuCell Corporation | 10.99 Million USD | 2772.83% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -90.572% |
| Onconetix, Inc. | 5.33 Million USD | 5609.94% |
| PureTech Health plc | -167.19 Million USD | -75.696% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -864.409% |
| Elevation Oncology, Inc. | -19.11 Million USD | -1436.557% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -5884.09% |
| Seer, Inc. | -4.24 Million USD | -6828.278% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -1122.112% |
| Innoviva, Inc. | 255.56 Million USD | 214.946% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -425.847% |
| ESSA Pharma Inc. | -33.62 Million USD | -773.721% |
| GlycoMimetics, Inc. | -40.98 Million USD | -616.758% |
| GT Biopharma, Inc. | -1.02 Million USD | -28671.694% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -333.382% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 579.552% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -119.094% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -2020.085% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -917.453% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -389842.124% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -851.847% |
| Aptose Biosciences Inc. | -8.19 Million USD | -3484.675% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -9288.217% |
| Soligenix, Inc. | -4.95 Million USD | -5832.611% |
| Century Therapeutics, Inc. | 847 Thousand USD | 34782.29% |
| Kura Oncology, Inc. | -20.11 Million USD | -1360.18% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -617.781% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -3397.964% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 16225.586% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -9088.583% |
| Autolus Therapeutics plc | -186.59 Million USD | -57.428% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -495.812% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | -6.514% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 957.24% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 278.72% |
| GRI Bio, Inc. | -1.79 Million USD | -16274.526% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -3170.149% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -783.3% |
| IGM Biosciences, Inc. | -72.6 Million USD | -304.593% |
| INmune Bio, Inc. | -25.41 Million USD | -1056.031% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 294.606% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -479.875% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1707.818% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -10082.549% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 872.745% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -613.267% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 1021.308% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 177.724% |
| Verastem, Inc. | -37.27 Million USD | -688.022% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -3137.727% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -466.424% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1840.925% |
| Histogen Inc. | -7.48 Million USD | -3823.588% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -1259.566% |
| Surrozen, Inc. | -32.66 Million USD | -799.336% |
| Organovo Holdings, Inc. | -1.5 Million USD | -19392.966% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -6888.458% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1649.345% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 11329.32% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 7168.311% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -3404.996% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -576.21% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1915.242% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 7.27% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -40583.461% |
| Apollomics, Inc. | -27.39 Million USD | -972.309% |
| Amarin Corporation plc | -191.04 Million USD | -53.768% |
| Mesoblast Limited | 55.96 Million USD | 624.916% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1914.255% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -1061.47% |
| Synaptogenix, Inc. | -28.66 Million USD | -924.925% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -31284.509% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 702.805% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -33975.252% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -3942.881% |
| Exelixis, Inc. | -73.05 Million USD | -302.134% |
| Better Therapeutics, Inc. | -860 Thousand USD | -34058.023% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -1123.333% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -21.704% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 40009.329% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -3849.364% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 23525.758% |
| Gritstone bio, Inc. | 39.49 Million USD | 843.882% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -249.293% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -11060.463% |
| Avid Bioservices, Inc. | 169.72 Million USD | 273.076% |
| Insmed Incorporated | 721.62 Million USD | 140.708% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -3113.462% |
| MediWound Ltd. | -5.32 Million USD | -5419.711% |
| OmniAb, Inc. | 9.2 Million USD | 3291.992% |
| Alector, Inc. | -35.63 Million USD | -724.309% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 441.695% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -5861.019% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 2318.891% |
| Zai Lab Limited | -775 Million USD | 62.096% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 186.259% |
| Aura Biosciences, Inc. | -21.52 Million USD | -1264.734% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -256.158% |
| Immunic, Inc. | -45.34 Million USD | -547.903% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -52.037% |
| Veracyte, Inc. | -203.82 Million USD | -44.124% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 146.023% |
| FibroGen, Inc. | 56.76 Million USD | 617.482% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 3398.81% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -10290.891% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -14088.871% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 106.399% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -8692.547% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -77.002% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1744.603% |
| Galecto, Inc. | -21.21 Million USD | -1284.611% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -1135.06% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 118.718% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -1100.388% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -2452.872% |
| XBiotech Inc. | -200.02 Million USD | -46.863% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -249.293% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 6587.61% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -733.052% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -280.428% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 5261.817% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -72.379% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -218.01% |
| Vaxxinity, Inc. | 10.13 Million USD | 2999.319% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 139.898% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -2628.188% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -345.386% |
| NexImmune, Inc. | -3.13 Million USD | -9274.361% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -8408.162% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1843.95% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -983.982% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -3172.697% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -235708.95% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -624.044% |
| Ainos, Inc. | 4.07 Million USD | 7303.634% |
| Pluri Inc. | 22.82 Million USD | 1386.78% |
| Prothena Corporation plc | -608.34 Million USD | 51.712% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -147.364% |
| Celularity Inc. | 65.19 Million USD | 550.62% |
| Rallybio Corporation | -24.1 Million USD | -1118.816% |
| Cue Biopharma, Inc. | -33.81 Million USD | -768.621% |
| MeiraGTx Holdings plc | -40.3 Million USD | -628.894% |
| Omeros Corporation | 331.17 Million USD | 188.702% |
| Humacyte, Inc. | -22.48 Million USD | -1206.408% |
| Immunocore Holdings plc | -358.59 Million USD | 18.08% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -1095.357% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -850.646% |
| Blueprint Medicines Corporation | 702.83 Million USD | 141.796% |
| CalciMedica, Inc. | -5.53 Million USD | -5212.098% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -56.072% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -2776.043% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -633.719% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -783.406% |
| Pulmatrix, Inc. | -10.41 Million USD | -2719.996% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -4814.823% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -670.172% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -163.693% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -390.056% |
| Cytokinetics, Incorporated | 642.37 Million USD | 145.73% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -4944.805% |
| Nutriband Inc. | -251.65 Thousand USD | -116629.914% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -760.984% |
| Vor Biopharma Inc. | 4.3 Million USD | 6931.605% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 95.133% |
| Evogene Ltd. | -19.63 Million USD | -1396.175% |
| ProKidney Corp. | -56.23 Million USD | -422.368% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -503.548% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -3080.178% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 121.538% |
| CorMedix Inc. | -43.05 Million USD | -582.327% |
| BioLineRx Ltd. | 7.33 Million USD | 4104.348% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -969.576% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 736.572% |
| Atai Life Sciences N.V. | -28.55 Million USD | -928.64% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 13269.925% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -1187.513% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1756.38% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -291.293% |
| MediciNova, Inc. | -50.78 Million USD | -478.453% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -272.767% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1305785.752% |
| GeoVax Labs, Inc. | -6.45 Million USD | -4452.576% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -47.011% |
| Biomea Fusion, Inc. | -166.57 Million USD | -76.358% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -64.134% |
| Mereo BioPharma Group plc | -51.46 Million USD | -470.749% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -209.729% |
| Absci Corporation | -72.59 Million USD | -304.638% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 6533.618% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -25.304% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -211.81% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -206.971% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -651.821% |
| Allakos Inc. | -24.97 Million USD | -1076.212% |
| Imunon, Inc. | -4.21 Million USD | -6871.27% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1892.667% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -116.956% |
| BioAtla, Inc. | -109.01 Million USD | -169.476% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 40009.329% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -31184.239% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 2554.947% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -1285.46% |
| XOMA Corporation | -29 Million USD | -912.962% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -1673.907% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -3158.197% |
| aTyr Pharma, Inc. | -7.44 Million USD | -3843.603% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -135.694% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -41.119% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -259.211% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -216.677% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -34090.464% |
| Akari Therapeutics, Plc | -3.84 Million USD | -7540.026% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 18200.98% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 121.273% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -24624.379% |
| UroGen Pharma Ltd. | 4.39 Million USD | 6790.025% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 358.862% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 408314.057% |
| Orgenesis Inc. | 21.78 Million USD | 1448.508% |
| Entera Bio Ltd. | -10.62 Million USD | -2663.75% |
| GH Research PLC | -78.07 Million USD | -276.243% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -1218.014% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -1001.913% |
| Xencor, Inc. | 29.64 Million USD | 1090.956% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -14813.048% |
| Replimune Group, Inc. | 1.41 Million USD | 20904.462% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -119846.674% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -132.373% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -24624.379% |
| Portage Biotech Inc. | -4.98 Million USD | -5797.591% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1305785.752% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -344.268% |
| OncoCyte Corporation | -6.56 Million USD | -4375.987% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 32833.981% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -6348.245% |
| Purple Biotech Ltd. | -14.13 Million USD | -1977.797% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -1136.568% |
| scPharmaceuticals Inc. | -6.54 Million USD | -4388.296% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -1659.862% |
| HilleVax, Inc. | -165.48 Million USD | -77.514% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -11474.429% |
| Tharimmune, Inc. | -10.93 Million USD | -2586.324% |
| Genprex, Inc. | -6.73 Million USD | -4259.976% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 20.349% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -232.081% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -20867.809% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -8756.309% |
| OKYO Pharma Limited | -826.84 Thousand USD | -35427.57% |
| Savara Inc. | 153 Thousand USD | 192099.346% |
| Curis, Inc. | -23.88 Million USD | -1129.786% |
| Daré Bioscience, Inc. | -5.15 Million USD | -5595.31% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -37754.956% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -4631.943% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 24889.789% |
| BeiGene, Ltd. | -2.25 Billion USD | 86.962% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 2480.832% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 51.701% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -58.287% |
| Erasca, Inc. | -37.21 Million USD | -689.335% |
| bluebird bio, Inc. | 108.57 Million USD | 370.569% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -22709.271% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 177.561% |
| DBV Technologies S.A. | -126.98 Million USD | -131.332% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -22709.271% |
| Moderna, Inc. | -2.9 Billion USD | 89.895% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -2737.703% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -2602.972% |
| Molecular Templates, Inc. | 707 Thousand USD | 41650.071% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -836.403% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 184.753% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -257.972% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -220.243% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -810.26% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -754.547% |
| MacroGenics, Inc. | -66.98 Million USD | -338.544% |
| RenovoRx, Inc. | -1.17 Million USD | -24943.393% |
| Adicet Bio, Inc. | -138.78 Million USD | -111.662% |
| Prime Medicine, Inc. | -27.94 Million USD | -951.355% |
| Aditxt, Inc. | 18.12 Million USD | 1721.107% |
| Adagene Inc. | -87.62 Million USD | -235.237% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -6952.313% |
| Quantum-Si incorporated | -118.55 Million USD | -147.779% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 915.884% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -3830.313% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -505.576% |
| SciSparc Ltd. | -2.06 Million USD | -14125.617% |
| Vericel Corporation | 1.27 Million USD | 23103.837% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2349.686% |
| Minerva Neurosciences, Inc. | 41 Million USD | 816.411% |
| Generation Bio Co. | 31.44 Million USD | 1034.11% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -67.514% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -849.969% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 351.953% |
| Invivyd, Inc. | -198.47 Million USD | -48.007% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -225.423% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -12151.759% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -314.972% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -4204.161% |
| 2seventy bio, Inc. | 181.71 Million USD | 261.659% |
| ADMA Biologics, Inc. | 90.06 Million USD | 426.16% |
| Clene Inc. | 3.34 Million USD | 8895.18% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -3134.268% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -1265.622% |
| GeoVax Labs, Inc. | -6.45 Million USD | -4452.576% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 14.636% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -1029.856% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 265.343% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -7079.621% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 5972.831% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -5539.451% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -125.441% |
| Evaxion Biotech A/S | 5.28 Million USD | 5656.415% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -160.961% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -123.777% |
| Trevena, Inc. | 2.25 Million USD | 13109.699% |
| Surrozen, Inc. | -32.66 Million USD | -799.336% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -470.295% |
| Cingulate Inc. | 3.08 Million USD | 9629.329% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -9902.009% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 4187.366% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -3061.681% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -270.333% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -123.472% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -178.334% |
| Clearmind Medicine Inc. | -3.94 Million USD | -7350.825% |
| Kronos Bio, Inc. | -36.05 Million USD | -714.775% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 3222.106% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 20246.325% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -441.431% |
| Statera Biopharma, Inc. | 14.41 Million USD | 2137.672% |
| ImmunityBio, Inc. | 618.22 Million USD | 147.517% |
| Korro Bio, Inc. | -132.94 Million USD | -120.966% |
| Kineta, Inc. | -4.54 Million USD | -6369.038% |
| BioVie Inc. | -17.73 Million USD | -1556.627% |
| Codexis, Inc. | -43.27 Million USD | -578.882% |
| Celularity Inc. | 65.19 Million USD | 550.62% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -9169.77% |
| Celcuity Inc. | 6.78 Million USD | 4430.487% |
| Virax Biolabs Group Limited | -3.36 Million USD | -8629.982% |
| Cibus, Inc. | -8.07 Million USD | -3536.531% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -6846.299% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 6527.987% |
| IN8bio, Inc. | -16.38 Million USD | -1692.416% |
| Kodiak Sciences Inc. | -103.87 Million USD | -182.8% |
| Annexon, Inc. | -193.75 Million USD | -51.614% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 816097.222% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -1578.719% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -8262.055% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 127.864% |
| Eyenovia, Inc. | 1.25 Million USD | 23438.248% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 1191.838% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -8958.249% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -783.565% |
| Arcellx, Inc. | -296.95 Million USD | 1.077% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -1405.993% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -398.954% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -1317.277% |
| Moolec Science SA | 117.61 Thousand USD | 249861.087% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -665.017% |
| Geron Corporation | 14.76 Million USD | 2090.102% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -674.722% |
| Royalty Pharma plc | 5.65 Billion USD | 105.192% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -107.72% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -4102.907% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -5377.657% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -108.738% |
| Humacyte, Inc. | -22.48 Million USD | -1206.408% |
| Structure Therapeutics Inc. | -124.33 Million USD | -136.256% |
| 89bio, Inc. | -289.05 Million USD | -1.628% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -1063.771% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -16375.547% |
| Genelux Corporation | -6.89 Million USD | -4157.994% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -845.81% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 451.391% |
| Notable Labs, Ltd. | -9.77 Million USD | -2904.9% |
| Liquidia Corporation | -80.17 Million USD | -266.393% |
| Mustang Bio, Inc. | -3.73 Million USD | -7762.928% |
| Immunovant, Inc. | -635.22 Million USD | 53.755% |
| Quantum-Si incorporated | -118.55 Million USD | -147.779% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -1572.506% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -6990.49% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 3759.636% |
| Acasti Pharma Inc. | -23 Million USD | -1176.935% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -8624.058% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1707.818% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -113.271% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -9326.344% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -1221.334% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -1481.986% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -73.536% |
| PepGen Inc. | -60.67 Million USD | -384.192% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -1178.547% |
| United Therapeutics Corporation | -507.7 Million USD | 42.139% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -1435.914% |
| Solid Biosciences Inc. | -47.75 Million USD | -515.202% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -33975.252% |
| Immuneering Corporation | -54.94 Million USD | -434.663% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -6888.458% |
| Silo Pharma, Inc. | -3.52 Million USD | -8235.225% |
| Belite Bio, Inc | -87.27 Million USD | -236.606% |
| XOMA Corporation | -29 Million USD | -912.962% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -315.518% |
| Bionomics Limited | 227 Million USD | 229.404% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -152.626% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -11497.276% |
| uniQure N.V. | -102.95 Million USD | -185.339% |
| Cassava Sciences, Inc. | -121.13 Million USD | -142.503% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -6952.313% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 817.343% |
| Forte Biosciences, Inc. | -11.96 Million USD | -2355.974% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -9393.859% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 277231.132% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -8958.249% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 3398.81% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -3861.152% |
| Altimmune, Inc. | -134.48 Million USD | -118.429% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 248.314% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -11497.276% |
| Compugen Ltd. | -12.9 Million USD | -2176.496% |
| Peak Bio, Inc. | 10.34 Million USD | 2940.953% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -103701.767% |
| Benitec Biopharma Inc. | -50.58 Million USD | -480.758% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -181.546% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1595.337% |
| Zura Bio Limited | -99.8 Million USD | -194.33% |
| PolyPid Ltd. | 6.17 Million USD | 4861.086% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 496.329% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1595.337% |
| Instil Bio, Inc. | 75.35 Million USD | 489.818% |
| argenx SE | -2.02 Billion USD | 85.521% |
| Immunome, Inc. | -97.02 Million USD | -202.754% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -1205.886% |
| Verona Pharma plc | -220.44 Million USD | -33.258% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -309.46% |
| Shattuck Labs, Inc. | -121.42 Million USD | -141.928% |
| CervoMed Inc. | -7.79 Million USD | -3669.598% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -58.362% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -6617.562% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -122.984% |
| Moolec Science SA | 117.61 Thousand USD | 249861.087% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -12739.246% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1947.729% |
| AnaptysBio, Inc. | -18.15 Million USD | -1518.418% |
| Design Therapeutics, Inc. | -18.15 Million USD | -1518.507% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -317.384% |
| NeurAxis, Inc. | 145.7 Thousand USD | 201719.08% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 2715.376% |
| Lumos Pharma, Inc. | -28.49 Million USD | -930.987% |
| Achilles Therapeutics plc | -126.92 Million USD | -131.445% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -309.46% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -44698.774% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -1314.082% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 20246.325% |
| Nutriband Inc. | -251.65 Thousand USD | -116629.914% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -2130.347% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -3848.374% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 186.35% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 1337.662% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 34.351% |
| Palisade Bio, Inc. | -12.06 Million USD | -2335.207% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -109.363% |
| Beam Therapeutics Inc. | -262.72 Million USD | -11.814% |
| Neurogene Inc. | -131.95 Million USD | -122.621% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 1446.53% |
| AEON Biopharma, Inc. | -4.88 Million USD | -5919.652% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 22.119% |
| Sesen Bio, Inc. | -112.55 Million USD | -160.996% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -194.171% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -12412.134% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -652.726% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -252.728% |
| Athira Pharma, Inc. | -88.99 Million USD | -230.07% |
| Vaccinex, Inc. | -1.28 Million USD | -22707.376% |
| HCW Biologics Inc. | 2.85 Million USD | 10383.245% |
| XOMA Corporation | -29 Million USD | -912.962% |
| Nektar Therapeutics | 210.24 Million USD | 239.726% |
| Arvinas, Inc. | -313.8 Million USD | 6.387% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 18200.98% |
| Merus N.V. | -192.88 Million USD | -52.298% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 589.721% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -4134.059% |
| Rezolute, Inc. | -68.16 Million USD | -330.934% |
| Clene Inc. | 3.34 Million USD | 8895.18% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -2127.641% |
| BeyondSpring Inc. | -13.75 Million USD | -2035.652% |
| Synlogic, Inc. | -6.68 Million USD | -4294.301% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 26004.674% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -3374.382% |
| Peak Bio, Inc. | 10.34 Million USD | 2940.953% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -256.417% |
| Krystal Biotech, Inc. | -350.23 Million USD | 16.125% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 336.664% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -73.826% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -9204.58% |
| MannKind Corporation | 143.89 Million USD | 304.142% |
| Ikena Oncology, Inc. | -109.15 Million USD | -169.119% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -3780.055% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -787.489% |
| Gossamer Bio, Inc. | 180.35 Million USD | 262.878% |
| CohBar, Inc. | -5.93 Million USD | -4853.167% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -887.492% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 6533.618% |
| Legend Biotech Corporation | -949.39 Million USD | 69.058% |
| Mural Oncology plc | -255.84 Million USD | -14.82% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 1011.87% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -6136.071% |
| Disc Medicine, Inc. | -358.28 Million USD | 18.009% |
| Champions Oncology, Inc. | 4.81 Million USD | 6204.717% |
| REGENXBIO Inc. | 54.76 Million USD | 636.37% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -109141.857% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -94.511% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -3159.641% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -264.09% |
| Vaxart, Inc. | -8.24 Million USD | -3464.604% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -485.411% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -131.005% |
| Cellectis S.A. | -43.85 Million USD | -569.842% |
| Longeveron Inc. | -2.9 Million USD | -10001.754% |
| Repare Therapeutics Inc. | -107.85 Million USD | -172.357% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 130.335% |
| Inozyme Pharma, Inc. | 12 Million USD | 2547.176% |
| Revolution Medicines, Inc. | -608.2 Million USD | 51.701% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -23782.846% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | -10.804% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -95.745% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -1777.414% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -39597.162% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 96.928% |
| Denali Therapeutics Inc. | -74.86 Million USD | -292.385% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2349.686% |
| Veru Inc. | 4.77 Million USD | 6245.626% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -2512.12% |
| Cingulate Inc. | 3.08 Million USD | 9629.329% |
| Passage Bio, Inc. | 4.58 Million USD | 6506.957% |
| Context Therapeutics Inc. | -14.44 Million USD | -1932.959% |
| Exicure, Inc. | 5.84 Million USD | 5122.38% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -27.513% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -642.378% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1972.15% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -399.412% |
| Nuvalent, Inc. | -335.38 Million USD | 12.412% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 17037.788% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -294.403% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -3204.376% |
| OmniAb, Inc. | 9.2 Million USD | 3291.992% |
| Anew Medical, Inc. | 1.43 Million USD | 20607.238% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1893.208% |
| Lipocine Inc. | -4.75 Million USD | -6078.427% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -167.472% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 2028.691% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -479.875% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 1280.134% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -4270.763% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -346.259% |
| Ocugen, Inc. | -32.52 Million USD | -803.29% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -243.277% |
| Q32 Bio Inc. | -37.94 Million USD | -674.109% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -46676.911% |
| Alumis Inc. Common Stock | -13.52 Million USD | -2071.328% |
| Equillium, Inc. | -22.39 Million USD | -1211.893% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -1048.932% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -800.362% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -118391.822% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 319.154% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 9285.71% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 89540.417% |
| Dominari Holdings Inc. | 195 Thousand USD | 150745.641% |
| Edesa Biotech, Inc. | -5.26 Million USD | -5477.445% |
| vTv Therapeutics Inc. | -8.91 Million USD | -3194.37% |
| Bio-Techne Corporation | 267.74 Million USD | 209.715% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -1712.32% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -148.75% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -3395.882% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -2222.022% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -19.843% |
| Nkarta, Inc. | 57.29 Million USD | 612.677% |
| BioCardia, Inc. | 212 Thousand USD | 138665.566% |
| Iterum Therapeutics plc | 13.43 Million USD | 2286.032% |